Show simple item record

dc.contributor.authorSmith, V
dc.contributor.authorWarty, RR
dc.contributor.authorKashyap, R
dc.contributor.authorNeil, P
dc.contributor.authorAdriaans, C
dc.contributor.authorNair, A
dc.contributor.authorKrishnan, S
dc.contributor.authorDa Silva Costa, F
dc.contributor.authorVollenhoven, B
dc.contributor.authorWallace, EM
dc.date.accessioned2021-10-14T04:47:01Z
dc.date.available2021-10-14T04:47:01Z
dc.date.issued2020
dc.identifier.issn2045-2322en_US
dc.identifier.doi10.1038/s41598-020-60040-3en_US
dc.identifier.urihttp://hdl.handle.net/10072/409075
dc.description.abstractExternal cephalic version (ECV) is associated with a moderate degree of pain. Virtual reality (VR) is a technology that has shown promise in offering procedural analgesia. We undertook a clinical pilot to assess the viability of VR to reduce pain during ECV. In an open randomised controlled trial (RCT), we randomised 50 women to either VR or standard care each (25 per group). Women receiving VR were administered VR content (Skylights) via a headset. Pre- and post-procedural measures of pain, anxiety, device experience and vital signs were measured. There were no significant differences between groups (VR/no VR) in pain scores (60.68 vs 49.76; p = 0.2), ECV success rates (80% vs 76%; p = 0.7) or anxiety levels. The women receiving VR had a significantly higher anticipation of pain pre-procedurally (70.0 vs 50.0; p = 0.03). 20 (80%) of the VR women indicated that they would use VR again and 22 (88%) indicated they would recommend it to a friend having ECV. There were no significant differences between groups for side effects encountered or changes in vital signs. We have shown that using VR during ECV is feasible and appears safe. Our results inform the design of future RCTs.en_US
dc.description.peerreviewedYesen_US
dc.languageengen_US
dc.publisherSpringer Science and Business Media LLCen_US
dc.relation.ispartofpagefrom3141en_US
dc.relation.ispartofissue1en_US
dc.relation.ispartofjournalScientific reportsen_US
dc.relation.ispartofvolume10en_US
dc.subject.fieldofresearchInformation systemsen_US
dc.subject.fieldofresearchClinical sciencesen_US
dc.subject.fieldofresearchcode4609en_US
dc.subject.fieldofresearchcode3202en_US
dc.titleA randomised controlled trial to assess the feasibility of utilising virtual reality to facilitate analgesia during external cephalic versionen_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Articlesen_US
dcterms.bibliographicCitationSmith, V; Warty, RR; Kashyap, R; Neil, P; Adriaans, C; Nair, A; Krishnan, S; Da Silva Costa, F; Vollenhoven, B; Wallace, EM, A randomised controlled trial to assess the feasibility of utilising virtual reality to facilitate analgesia during external cephalic version, Scientific reports, 2020, 10 (1), pp. 3141-en_US
dcterms.dateAccepted2020-01-14
dc.date.updated2021-10-12T23:52:23Z
gro.hasfulltextNo Full Text
gro.griffith.authorDa Silva Costa, Fabricio


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record